ROYCE & ASSOCIATES LP - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 171 filers reported holding ANI PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2020$34,000
+17.2%
1,036
+47.4%
0.00%
Q1 2020$29,000
-14.7%
703
+25.8%
0.00%
Q4 2019$34,000
-10.5%
559
+8.5%
0.00%
Q3 2019$38,000
+40.7%
515
+55.1%
0.00%
Q2 2019$27,000
-3.6%
332
-15.7%
0.00%
Q1 2019$28,000
+75.0%
394
+13.9%
0.00%
Q4 2018$16,000
-30.4%
346
-14.4%
0.00%
Q3 2018$23,0004040.00%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q4 2018
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders